Correlation Between Nuvalent and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Travere Therapeutics, you can compare the effects of market volatilities on Nuvalent and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Travere Therapeutics.
Diversification Opportunities for Nuvalent and Travere Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nuvalent and Travere is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Travere Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Nuvalent is 1.39 times less risky than Travere Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,810 in Travere Therapeutics on November 2, 2024 and sell it today you would earn a total of 295.00 from holding Travere Therapeutics or generate 16.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Travere Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Travere Therapeutics |
Nuvalent and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Travere Therapeutics
The main advantage of trading using opposite Nuvalent and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |